Therapeutic Interactive Voice Response (TIVR) to Reduce Analgesic Medication Use for Chronic Pain Management


      This paper examines whether a telephone-based, automated maintenance enhancement program can help to reduce opioid and nonsteroidal anti-inflamatory drugs (NSAID) analgesic use in patients with chronic pain. Following 11 weeks of group cognitive-behavioral therapy (CBT), 51 subjects with chronic musculoskeletal pain were randomized to 1 of 2 study groups. Twenty-six subjects participated in 4 months of a Therapeutic Interactive Voice Response (TIVR) program in addition to standard follow-up care, while a control group of 25 subjects received standard follow-up care only. TIVR is an automated, telephone-based tool developed for the maintenance and enhancement of CBT skills. Opioid analgesic use decreased in the experimental group in both follow-ups: 4 and 8 months postCBT. In addition, at 8-month follow-up, 21% of the TIVR subjects had discontinued the use of opioid analgesics, 23% had discontinued NSAIDS, and 10% had discontinued antidepressant medications. In contrast, the control group showed increases in opioid and NSAIDS use. Analysis of covariance (ANCOVA) revealed significant between-group differences in opioid analgesic use at 8-month follow up (P = .004). We have previously demonstrated the efficacy of TIVR to decrease pain and improve coping; this analysis demonstrates that the use of TIVR may also result in concurrent reductions in opioid analgesic and NSAID medications use.


      This article demonstrates that the Therapeutic Interactive Voice Response maintenance enhancement program can help to reduce opioid analgesic use in patients with chronic pain. This automated maintenance enhancement program could potentially assist patients not only to decrease pain and improve coping, but also to diminish the likelihood of opioid dependence.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. American Pain Society: Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain, 5th ed. Glenview, III, American Pain Society, 2003

        • Basler H.
        Group treatment for pain and discomfort.
        Patient Educ Couns. 1993; 20: 167-175
        • Basler H.
        • Jakle C.
        • Kroner-Herwig B.
        Incorporation of cognitive-behavioral treatment into the medical care of chronic low back patients: A controlled randomized study in German pain treatment centers.
        Patient Educ Couns. 1997; 31: 113-124
      2. Beck A, Steer R, Brown GK: Manual for the Beck Depression Inventory II (BDI-II), 2nd ed. San Antonio, TX, Psychology Corporation, 1996

      3. Bezchlibnyk-Butler KZ, Jeffries JJ. Clinical handbook of psychotropic drugs, 12th ed. Toronto, Hogrefe & Huber, 2002

      4. Cohen J: Statistical Power Analyses for the Behavioral Sciences. Hillsdale, NJ, Lawrence Erlbaum Associates, Inc., 1988

        • Compas B.
        • Haaga D.
        • Keefe F.
        • Leitenberg H.
        • Williams D.
        A sampling of empirically supported psychological treatments for health psychology: Smoking, chronic pain, cancer, & bulimia nervosa.
        J Consult Clin Psychol. 1998; 66: 89-112
        • Connally G.
        • Sanders S.
        Predicting low back pain patients' response to lumbar sympathetic nerve blocks and interdisciplinary rehabilitation: The role of pretreatment overt pain behavior and cognitive coping strategies.
        Pain. 1991; 44: 139-146
        • Dozois D.
        • Covin R.
        The Beck Depression Inventory-II (BDI-II), Beck Hopelessness Scale (BHS), and Beck Scale for Suicide Ideation (BSS).
        in: Hersen M. Hilsenroth M. Segal D. Comprehensive Handbook of Psychological Assessment: Personality Assessment, volume 2. John Wiley and Sons, Inc., New York, NY2004: 50-69
        • Ehrlich G.
        Future directions in therapy of pain and osteoarthritis.
        Semin Arthritis Rheum. 1989; 18: 100-104
        • Fishbain D.
        • Cutler R.
        • Rosomoff H.
        • Rosomoff R.
        Chronic pain-associated depression: Antecedent or consequence of chronic pain? A review.
        Clin J Pain. 1997; 13: 116-137
        • Gandek B.
        • Ware Jr., J.
        Translating functional health and well-being: International Quality Of Life Assessment (IQOLA) Project studies of the SF-36 health survey.
        J Clin Epidemiol. 1998; 51: 891-1214
        • Goodman L.S.
        • Gilman A.
        The Pharmacological Basis of Therapeutics.
        11th ed. McGraw-Hill, New York, NY2005
        • Keefe F.
        • Caldwell D.
        • Martinez S.
        • Nunley J.
        • Williams D.
        Analyzing pain in rheumatoid arthritis patients: Pain coping strategies in patients who have had knee replacement surgery.
        Pain. 1991; 46: 153-160
        • Keefe F.
        • Van Horn Y.
        Cognitive-behavioral treatment of rheumatoid arthritis pain: Understanding and enhancing maintenance of treatment gains.
        Arthritis Care Res. 1993; 6: 213-222
        • Lanes T.
        • Gauron E.
        • Spratt K.
        • Wernimont T.
        • Found E.
        • Weinstein J.
        Long-term follow-up of patients with chronic back pain treated in a multidisciplinary rehabilitation program.
        Spine. 1995; 20: 801-806
        • Lawson K.
        • Reesor K.
        • Keefe F.
        • Turner J.
        Dimensions of pain-related cognitive coping: Cross-validation of the factor structure of the coping strategy questionnaire.
        Pain. 1990; 43: 195-204
        • Melzack R.
        The McGill pain questionnaire: Major properties and scoring methods.
        Pain. 1975; 1: 277-299
        • Naylor M.
        • Helzer E.
        • Naud S.
        • Keefe F.
        Automated telephone as an adjunct for the treatment of chronic pain: A pilot study.
        J Pain. 2002; 3: 429-438
        • Naylor M.
        • Keefe F.
        • Brigidi B.
        • Naud S.
        • Helzer E.
        Therapeutic interactive voice response for chronic pain reduction and relapse prevention.
        Pain. 2008; 134: 335-345
        • Porter J.
        • Jick H.
        Addiction rare in patients treated with narcotics.
        N Engl J Med. 1981; 302: 125
        • Rogers W.
        • Wittink H.
        • Ashburn M.
        • Cynn D.
        • Carr D.
        Using the TOPS as an outcomes instrument for multidisciplinary outpatient pain treatment by means of an augmented SF-36.
        Pain Medicine. 2000; 1: 55-67
        • Rogers W.
        • Wittink H.
        • Wagner A.
        • Cynn D.
        • Carr D.
        Assessing individual outcomes during outpatient multidisciplinary chronic pain treatment by means of an augmented SF-36.
        Pain Med. 2000; 1: 44-54
        • Salerno S.M.
        • Browning R.
        • Jackson J.L.
        The effect of antidepressant treatment on chronic back pain: A meta-analysis.
        Arch Intern Med. 2002; 162: 19-24
        • Schnitzer T.
        Osteoarthritis treatment update.
        Postgrad Med. 1993; 93: 89-95
        • Simmonnet G.
        • Le Moal M.
        Vulneability to opioid tolerance, dependence, and addiction: An individual-centered versus drug-centered paradigm analysis.
        in: Beaulieu P. Lussier D. Porreca F. Dickenson A.H. Pharmacology of Pain. 1st ed. IASP, Seattle, WA2010: 405-429
        • Staiger T.
        • Gaster B.
        • Sullivan M.
        • Deyo R.
        Systematic review of antidepressants in the treatment of low back pain.
        Spine. 2003; 28: 2540-2545
      5. Substance Abuse and Mental Health Services Administration. (2009). Results from the 2008 National Survey on Drug Use and Health: National Findings. (Office of Applied Studies), NSDUH Series H-36, HHS Publication No. SMA 09-4443). Rockville, MD, 2009

        • Turk D.
        • Rudy T.
        Neglected topics in the treatment of chronic pain patients–relapse, noncompliance, and adherence enhancement.
        Pain. 1991; 44: 5-28
      6. Urquhart DM, Hoving JL, Assendelft WJJ, Roland M, van Tulder MW: Antidepressants for non-specific low back pain. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD001703, 2008

        • Vlaeyen J.
        • Haazen I.
        • Schuerman J.
        • Kole-Snijders A.
        • van Eek H.
        Behavioral rehabilitation of chronic low back pain: Comparison of an operant treatment, an operant-cognitive treatment and an operant-respondent treatment.
        Br J Clin Psychol. 1995; 34: 95-118
        • Wartenbert A.
        The opiate and opiate abuse, in Herrington R, Jacobson G, Benzer D (eds): Alcohol and Drug Abuse.
        1st ed. Warren H. Green, Inc., St. Louis, MO1987
        • Weilburg J.
        • O'Leary K.
        • Meigs J.
        • Hennen J.
        • Stafford R.
        Evaluation of the adequacy of outpatient antidepressant treatment.
        Psychiatr Serv. 2003; 54: 1233-1238